日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Protumorigenic Responses of CEACAM6 in Helicobacter pylori-Infected Gastric Cancer Cells.

CEACAM6 在幽门螺杆菌感染的胃癌细胞中的促肿瘤反应。

Chakraborty Debashish, Poirah Indrajit, Samal Supriya, Banerjee Smaran, Pal Aranya, Mahish Chandan, Chattopadhyay Subhasis, Kanungo Girija Nandini, Samantasinhar Pusparaj, Nath Gautam, Rout Niranjan, Singh Shivaram Prasad, Bhattacharyya Asima

Integrative Omics Analysis Reveals the Potential Value of CEACAM6 in Pan-Gastrointestinal Cancers

整合组学分析揭示CEACAM6在泛胃肠道癌症中的潜在价值

Jin, Liying; Tao, Changjuan; Pan, Zhiyong; Zhang, Peng

The PTPN2 rs1893217 IBD risk allele increases susceptibility to AIEC invasion by a JAK-STAT-CEACAM6 axis.

PTPN2 rs1893217 IBD 风险等位基因通过 JAK-STAT-CEACAM6 轴增加 AIEC 侵袭的易感性

Chatterjee Pritha, Canale Vinicius, King Stephanie J, Shawki Ali, Lei Hillmin, Santos Alina N, Haddad Michael, Gries Casey, McGovern Dermot P B, Borneman James, McCole Declan F

Cytokine and epigenetic regulation of CEACAM6 mediates EGFR-driven signaling and drug response in lung adenocarcinoma.

细胞因子和表观遗传调控 CEACAM6 介导肺腺癌中 EGFR 驱动的信号传导和药物反应

Zheng Ming-Yi, Lin Yen-Ting, Kuo Yen-Shou, Lin Yen-Ju, Kuo Ming-Han, Huang Tsai-Wang, Shieh Yi-Shing, Huang Yenlin, Chou Yu-Ting

CEACAM6 as a machine learning derived immune biomarker for predicting neoadjuvant chemotherapy response in HR+/HER2- breast cancer

CEACAM6作为一种基于机器学习的免疫生物标志物,可用于预测HR+/HER2-乳腺癌新辅助化疗的疗效

Fang, Dalang; Lin, Jie; Wang, Jin; Nong, Qingxiao; Tao, Shouwen; Lu, Bimin; Yu, Yanrong; Peng, Hao; Tian, Yingying; Su, Qunying; Ma, Yanfei; Huang, Yuanlu

Molecular profiling and bioinformatics validation of CEACAM6, HOXA-AS3 and miR29a in colorectal cancer

结直肠癌中CEACAM6、HOXA-AS3和miR29a的分子谱分析和生物信息学验证

Bahramian, Shabbou; Akbar, Soroush; Nikoo, Mohammad Hadi Razavi; Amini, Abolfazl; Shamsabadi, Fatemeh Tash

CEACAM6 regulates glycolytic metabolism in bladder cancer cell by controlling ENO1 stability.

CEACAM6 通过控制 ENO1 的稳定性来调节膀胱癌细胞的糖酵解代谢。

Wang Pu, Li Changchang, Xu Yangyang, Altuwaijri Saleh, Niu Yuanjie, Zhao Yang, Jiang Ning

Targeted Suppression of CEACAM6 via pHLIP-Delivered RNAs in Pancreatic Ductal Adenocarcinoma

利用pHLIP递送的RNA靶向抑制胰腺导管腺癌中的CEACAM6

Kim, Hongsik; Woo, Chang-Gok; Son, Seung-Myoung; Lee, Yong-Pyo; Kim, Hee-Kyung; Yang, Yaewon; Kwon, Jihyun; Lee, Ki-Hyeong; Lee, Ho-Chang; Lee, Ok-Jun; Han, Hye-Sook

Multicenter validation of CEACAM6 and FOXP3 as robust prognostic biomarkers in colon cancer: Combined immunohistochemical and transcriptomic analysis.

CEACAM6 和 FOXP3 作为结肠癌可靠预后生物标志物的多中心验证:免疫组织化学和转录组学联合分析。

Liu Yingying, Ye Jianxin, Ma Jinzhao, Pan Xingxiao

[CEACAM6 inhibits proliferation and migration of nasopharyngeal carcinoma cells by suppressing epithelial-mesenchymal transition]

[CEACAM6通过抑制上皮-间质转化来抑制鼻咽癌细胞的增殖和迁移]

Tao, Lu; Wei, Zhuoli; Wang, Yueyue; Xiang, Ping